Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2889 results

Sort By:

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Study ID: NCT07349693
Start Date: 2026-11-01
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

175

Intervention / Treatment

Cerebraca wafer

Temozolomide (for relapsed malignant glioma)

Sponsor

Everfront Biotech Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)

Study ID: NCT07412626
Start Date: 2026-04-01
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

135

Intervention / Treatment

Heartlogic Diagnostic Tool Threshold Change

Heartlogic Diagnostic Tool Unchanged Threshold

Sponsor

Robert Pickett

Source: clinicaltrials.gov

Share:
Add to list

Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment

Study ID: NCT06855433
Start Date: 2026-04-10
End Date: 2029-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Colchicine Pill

Placebo

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations

Study ID: NCT07053514
Start Date: 2027-07
End Date: 2028-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

139

Intervention / Treatment

SD-ART

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Perioperative Nutrition Optimization for Reducing Complications After Surgical Fracture Fixation

Study ID: NCT07155447
Start Date: 2026-06-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1000

Intervention / Treatment

CEAA supplementation

Placebo

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer

Study ID: NCT07405385
Start Date: 2026-09
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

44

Intervention / Treatment

Control

Exercise

Sponsor

University of Castilla-La Mancha

Source: clinicaltrials.gov

Share:
Add to list

The Agenda-Setting for Kidney Disease Open Pilot Trial

Study ID: NCT07221604
Start Date: 2026-07
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Chronic Kidney Disease Structured Agenda-Setting Tool

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Connecting People With Cancer to Employment Support

Study ID: NCT07027449
Start Date: 2028-01
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Screening and Referral Workflow

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

ProofPrinciple IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophageal Adenocarcinoma w/ARID1a In

Study ID: NCT06824363
Start Date: 2026-04
End Date: 2028-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

34

Intervention / Treatment

Tremelimumab

Durvalumab

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

Study ID: NCT07413952
Start Date: 2026-04-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Limertinib Plus Radiotherapy

Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Source: clinicaltrials.gov

Share:
Add to list